| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.032 | 0.8 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.037 | 0.8 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |